Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Contemporary Clinical Trials|December 17, 2014
Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eSWenbin Lu, Lijuan Chen, Yu Wang, et al.American Journal of Translational Research|January 26, 2016
Factor Xa induces pro-inflammatory cytokine expression in RAW 264.7 macrophages via protease-activated receptor-2 activationPengfei Zuo, Zhi Zuo, Xin Wang, et al.International Journal of Nanomedicine|November 23, 2018
Inverse opal substrate-loaded mesenchymal stem cells contribute to decreased myocardial remodeling after transplantation into acute myocardial infarction miceWenbin Lu, JingJing Ji, Genshan Ma, et al.Biochemical and Biophysical Research Communications|March 25, 2020
Protease-activated receptor 2 deficiency in hematopoietic lineage protects against myocardial infarction through attenuated inflammatory response and fibrosisPengfei Zuo, Yinghong Zhu, Yongjun Li, et al.BMC Cardiovascular Disorders|June 7, 2022
Spontaneous left main coronary artery dissection occurred in a young male: a case report and review of literatureYongjun Li, Mingming Yang, Xi Chen, et al.Organic & Biomolecular Chemistry|May 30, 2025
Recent advances in photo-promoted generalized C3-H alkylation of quinoxalin-2(1H)-onesYoupeng Zuo, Xiufang Bai, Cong Wang, et al.Organic & Biomolecular Chemistry|June 4, 2024
Recent approaches for the synthesis of heterocycles from amidines via a metal catalyzed C-H functionalization reactionYoupeng Zuo, Pengfei Zuo, Meijun Liu, et al.Journal of Interventional Cardiology|January 12, 2023
Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome PatientsYongjun Li, Mingming Yang, Xi Chen, et al.BMC Genomics|August 13, 2022
Upregulation of key genes Eln and Tgfb3 were associated with the severity of cardiac hypertrophyRui Zhang, Xuan Xu, Xi Chen, et al.Frontiers in Oncology|January 28, 2026
miR-221/222-3p act as potential circulating factors in heart failure to stimulate cancer progressionRongfeng Xu, Jiaqi Guo, Zhenjun Ji, et al.Pageof 3